C9ORF85 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.414000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.339000E-01
Normal-vs-Stage2
6.495800E-01
Normal-vs-Stage3
5.441600E-01
Normal-vs-Stage4
9.539400E-01
Stage1-vs-Stage2
9.213200E-01
Stage1-vs-Stage3
7.328600E-01
Stage1-vs-Stage4
6.836800E-01
Stage2-vs-Stage3
5.509600E-01
Stage2-vs-Stage4
6.567400E-01
Stage3-vs-Stage4
5.612200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.663600E-01
Normal-vs-AfricanAmerican
4.073000E-01
Normal-vs-Asian
3.713000E-01
Caucasian-vs-AfricanAmerican
5.003000E-01
Caucasian-vs-Asian
6.033600E-01
AfricanAmerican-vs-Asian
7.699400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.880800E-01
Normal-vs-Female
5.750000E-01
Male-vs-Female
7.272200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.523030E-01
Normal-vs-Age(41-60Yrs)
9.852200E-01
Normal-vs-Age(61-80Yrs)
4.939600E-01
Normal-vs-Age(81-100Yrs)
9.272800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.368400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.838400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.272400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.265760E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.765200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.472200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.518800E-01
Normal-vs-Daily Drinker
5.421800E-01
Normal-vs-Weekly Drinker
5.972400E-01
Normal-vs-Occasional Drinker
4.455200E-01
Normal-vs-Social Drinker
8.777200E-01
Non Drinker-vs-Daily Drinker
9.810800E-01
Non Drinker-vs-Weekly Drinker
9.561000E-01
Non Drinker-vs-Occasional Drinker
6.793800E-01
Non Drinker-vs-Social Drinker
1.674970E-01
Daily Drinker-vs-Weekly Drinker
9.427000E-01
Daily Drinker-vs-Occasional Drinker
7.174200E-01
Daily Drinker-vs-Social Drinker
1.850410E-01
Weekly Drinker-vs-Occasional Drinker
7.399000E-01
Weekly Drinker-vs-Social Drinker
2.575600E-01
Occasional Drinker-vs-Social Drinker
2.422800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.600400E-01
Normal-vs-Grade 2
8.919200E-01
Normal-vs-Grade 3
8.121400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.447400E-01
Grade 1-vs-Grade 3
5.177900E-02
Grade 1-vs-Grade 4
9.600400E-01
Grade 2-vs-Grade 3
1.496590E-01
Grade 2-vs-Grade 4
8.919200E-01
Grade 3-vs-Grade 4
8.121400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.659800E-01
Normal-vs-NonDiabetic
6.270600E-01
Diabetic-vs-NonDiabetic
3.010400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.222400E-01
Normal-vs-NoPancreatitis
6.447400E-01
Pancreatitis-vs-NoPancreatitis
4.532800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.048000E-01
Normal-vs-N1
6.474000E-01
N0-vs-N1
8.188000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.412200E-01
Normal-vs-TP53-NonMutant
9.789600E-01
TP53-Mutant-vs-TP53-NonMutant
8.962600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
